Penumbra Inc Dossier
Qualitative Analysis
Business overview
Penumbra, Inc. is a global healthcare company that designs, develops, manufactures, and markets innovative medical devices. The company is a pioneer and market leader in the field of thrombectomy, focusing on computer-assisted vacuum thrombectomy (CAVT) technologies. Its broad product portfolio is designed to address challenging medical conditions head-to-toe, including ischemic stroke, venous thromboembolism (such as pulmonary embolism), and acute limb ischemia. Penumbra operates primarily through a direct sales organization in the United States, Canada, Australia, and most of Europe, while utilizing distributors in select international markets. The company operates as a single business segment.
Research as of 19 Jun 2026
Strategic Initiatives
Growth programs, investments, and their expected impact
Broadening the commercial footprint of Computer Assisted Vacuum Thrombectomy (CAVT) systems, including the Lightning Flash and Lightning Bolt portfolios, across international markets such as Europe and Asia.
Expected impact: Diversification of the revenue base and increased utilization of advanced thrombectomy platforms outside the United States.
Establishing a state-of-the-art manufacturing facility and warehouse in the La Lima Free Zone, Cartago, Costa Rica, to scale production of CAVT systems.
Expected impact: Creation of over 200 jobs and significant expansion of global production capacity to support international adoption.
Mergers, Acquisitions & Partnerships
Recent deals and strategic collaborations
Recent Acquisitions
To integrate Penumbra's leading head-to-toe thrombectomy and embolization portfolios into Boston Scientific's vascular and cardiovascular device offerings, entering fast-growing segments.
Financial impact: Valued at $374 per share in a cash and stock transaction (roughly 73% cash and 27% stock).